← Leaderboards
Nicolas Wein
Research Inst Nationwide Children'S Hosp
$1,575,141
Attributed
$2,573,532
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $487.9K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,573,532 · 2
By mechanism
R01$1,996,783 · 1
P50$576,749 · 1
Top collaborators
- Kathrin Meyer5 shared
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesResearch PersonnelCommunitiesGene TherapyPatternProductionMuscleDisease PhenotypeDisease ModelDoseAdeno-Associated Viral VectorBiodistributionAnterograde TransportBloodCostAreaDrug DevelopmentBody WeightBrain TissueBurden Of IllnessAdultAdolescentAffectChild
Grant awards (7)
Muscular Dystrophy Cell Line and Serum Banking Core$282,014
P50 · FY2025 · HD · contact PI
Muscular Dystrophy Cell Line and Serum Banking Core$294,735
P50 · FY2024 · HD · contact PI
Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders$321,752
R01 · FY2023 · AR · contact PI
Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders$345,017
R01 · FY2022 · AR · contact PI
Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders$382,447
R01 · FY2021 · AR · contact PI
Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders$487,911
R01 · FY2020 · AR · contact PI
Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders$459,656
R01 · FY2019 · AR · contact PI